White House Adviser Says Trump Won’t Create ‘FDA for AI’ - PYMNTS.com
Evolving story · 2 updatesThe AI Regulation DebateTimeline →The Trump administration will not create a regulatory body for AI, according to a White House adviser. This decision may impact the development and deployment of AI technologies.
- The Trump administration will not create a regulatory body for AI
- This decision may impact AI development and deployment in various industries
- Lack of regulation could lead to uncertainty and variability in AI governance
The Trump administration has decided not to establish a regulatory body for artificial intelligence, similar to the FDA for food and drugs.
This decision may have significant implications for the development and deployment of AI technologies in various industries.
The lack of a dedicated regulatory body could lead to increased uncertainty and variability in AI governance, potentially affecting businesses and consumers alike.
As AI continues to play a larger role in everyday life, the need for clear guidelines and oversight may become more pressing, leading to potential future revisions of this decision.
Source: White House Adviser Says Trump Won’t Create ‘FDA for AI’ - PYMNTS.com. Read the full piece at the source.
may face uncertainty and variability in AI governance
may be affected by lack of clear guidelines for AI development and deployment